Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance

Clinical trial NCT05692635 · RECRUITING

Trial details

NCT number: NCT05692635
Sponsor: Wake Forest University Health Sciences
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Brain Metastases Nonsmall Cell Lung Cancer Stage III

Start date: 2023-08-30
Primary completion: 2028-04-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.